Tab. II.
The challenges of the Iranian health system in fighting COVID-19; organizational factors.
| Themes | Line-managers | Staff-managers | Sub-themes and related codes | |
|---|---|---|---|---|
| Processes and instructions | ✓ | ✓ | Executive instructions | Dispersion, lack of transparency, and executive capacity of some of the laws and instructions proposed by the Ministry of Health and the World Organization |
| ✓ | ✓ | Repetitive changes in the protocols especially in the early stage of the pandemic | ||
| ✓ | Delay in sending instructions by the Ministry of Health | |||
| ✓ | ✓ | Choosing a hospital as the referral hospital | ||
| ✓ | ✓ | Medical and pharmacological protocols | Lack of treatment method or standard drug for the disease | |
| ✓ | ✓ | Repetitive changes in the treatment and medication protocols | ||
| ✓ | ✓ | Intra-sector and extra-sector coordination | Lack of intra-sector and extra-sector coordination in the early stages of the pandemic | |
| ✓ | The time-consuming process of attracting new human forces | |||
| ✓ | Lack of coordination and agreement among the different deputies of the university about human force attraction | |||
| Infrastructural factors | ✓ | Staff | Lack of experience in hospitals to fight with such prevalent respiratory diseases | |
| ✓ | The change in the human force structure in the area of treatment of (non-communicable diseases) compared to hygiene in the recent years | |||
| ✓ | ✓ | Lack of specialist forces in some regions especially in the area of infectious diseases, ICU, pulmonary, and internal diseases | ||
| ✓ | ✓ | Information technology | Lack of virtual education infrastructures | |
| ✓ | ✓ | Lack of a comprehensive centralized system for registering the positive cases of coronavirus and failure to analyze the data on time for proper decision making | ||
| ✓ | Lack of electronic health records and previous records and information of the patients’ underlying diseases | |||
| ✓ | Physical | Lack of proper diagnostic infrastructures in the country | ||
| ✓ | ✓ | Lack of the necessary infrastructure to prepare a large amount of the consumer and protective equipment | ||
| ✓ | Lack of readiness of drug distribution network of Food and Drug Administration | |||
| ✓ | Lack of protective equipment producing companies in the country | |||